Integrating a Telemonitoring Device into the Outpatient Management of Adult Patients Following Intensive Chemotherapy for Acute Myeloid Leukemia (AML) and High-Grade Myelodysplastic Syndrome (MDS): A Randomized Pilot Study

There is an ongoing effort towards shifting care to the outpatient setting following intensive chemotherapy for high-grade myeloid neoplasms, which is medically and logistically challenging for healthcare professionals, patients and caregivers. We hypothesize that in-home ( “telemonitoring”) devices which record vital signs, not previously tested in AML, may facilitate this approach. In this pilot study, we assessed how these devices can be integrated into the outpatient care of AML/MDS patients.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Source Type: research